why choose us

First received: June 04, 2023

Clinical Trial: Venetoclax Combined With Azactidine in the Treatment of ALAL

Study Status: Completed

Recruit Status: RECRUITING

Condition: Acute Leukemia of Ambiguous Lineage

Study Type: INTERVENTIONAL


Official Title: A Multicenter Prospective Clinical Study of Venetoclax Combined With Azactidine in the Treatment of Acute Leukaemias of Ambiguous Lineage

Brief Summary: The prognosis of acute leukaemias of ambiguous lineage is poor.The effect of chemotherapy regimen and hematopoietic stem cell transplantation are still unclear.Therefore, we will explore new therapy to improve the remission rate of acute leukaemias of ambiguous lineage.Venetoclax can significantly improve the remission rate and prolong PFS and OS.At present, venetoclax combined with azacitidine or decitabine has become the preferred treatment regimen for elderly AML patients.It also shows a high response rate in…

Read more